Three Finalists Announced for the 2023 Bloom Burton Award
Toronto, Ontario--(Newsfile Corp. - May 4, 2023) - Bloom Burton & Co. is pleased to announce the finalists for the 2023 Bloom Burton Award. Bestowed annually and nominated by the public at large, the Bloom Burton Award honours an individual who made the greatest contribution to Canada's innovative healthcare industry in the previous year. The finalists for 2023, in alphabetical order, are: Stephen Dilly, former President and Chief Executive Officer, Sierra Oncology Ian Mortimer, President and...
2023-05-04 7:00 AM EDT
BetterLife Pharma to Present at the 2023 Bloom Burton & Co. Healthcare Investor Conference
Vancouver, British Columbia--(Newsfile Corp. - April 24, 2023) - BetterLife Pharma (CSE: BETR), an emerging biotech company focused on the development and commercialization of cutting-edge treatments for mental disorders, will be participating in the 2023 Bloom Burton & Co. Healthcare Investor Conference, which will take place on April 25 and 26 at the Metro Toronto Convention Centre. Dates:Tuesday April 25, 2023-Wednesday April 26, 20
2023-04-24 8:00 AM EDT
OpSens Announces Participation in the 2023 Bloom Burton & Co. Healthcare Investor Conference
Quebec City, Quebec--(Newsfile Corp. - April 20, 2023) - OpSens (TSX: OPS) (OTCQX: OPSSF), a medical device cardiology-focused company delivering innovative solutions based on its proprietary optical technology, will be participating in the 2023 Bloom Burton & Co. Healthcare Investor Conference, which will take place on April 25 and 26 at the Metro Toronto Convention Centre. Dates:Tuesday April 25, 2023-Wednesday April 26, 2023
2023-04-20 9:00 AM EDT
Adaptiiv Medical Technologies Inc. to Present at the 2023 Bloom Burton & Co. Healthcare Investor Conference
Halifax, Nova Scotia--(Newsfile Corp. - April 20, 2023) - Adaptiiv Medical Technologies Inc., (Adaptiiv), an FDA cleared medical device software company, will be participating in the 2023 Bloom Burton & Co. Healthcare Investor Conference, which will take place on April 25 and 26 at the Metro Toronto Convention Centre. Dates:Tuesday April 25, 2023-Wednesday April 26, 2023
2023-04-20 8:00 AM EDT
Cipher Pharmaceuticals to Present at the 2023 Bloom Burton & Co. Healthcare Investor Conference
Mississauga, Ontario--(Newsfile Corp. - April 18, 2023) - Cipher Pharmaceuticals (TSX: CPH), a specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products, will be participating in the 2023 Bloom Burton & Co. Healthcare Investor Conference, which will take place on April 25 and 26 at the Metro Toronto Convention Centre. Dates:Tuesday April 25, 2023 and Wednesday Apri
2023-04-18 5:00 PM EDT
Theratechnologies to Present at the 2023 Bloom Burton & Co. Healthcare Investor Conference
Montreal, Quebec--(Newsfile Corp. - April 18, 2023) - Theratechnologies (NASDAQ: THTX) (TSX: TH), a biopharmaceutical company focused on the development and commercialization of innovative therapies, will be participating in the 2023 Bloom Burton & Co. Healthcare Investor Conference, which will take place on April 25 and 26 at the Metro Toronto Convention Centre. Dates:Tuesday April 25, 2023-Wednesday April 26, 2023
2023-04-18 7:30 AM EDT
Grey Wolf Animal Health to Present at The 2023 Bloom Burton & Co. Healthcare Investor Conference
Toronto, Ontario--(Newsfile Corp. - April 13, 2023) - Grey Wolf Animal Health Corp. (TSXV: WOLF) ("Grey Wolf" or the "Company"), a Canadian diversified animal health company, today announced that Angela Cechetto, CEO, is scheduled to present a corporate update at the 2023 Bloom Burton & Co. Healthcare Investor Conference on Tuesday April 25, 2023 at 2:30pm ET at the Metro Toronto Convention Centre in Toronto. Grey Wolf management will also be available for one-on-one meetings during both days...
2023-04-13 4:30 PM EDT
Congruence Therapeutics to Present at the 2023 Bloom Burton & Co. Healthcare Investor Conference
Montreal, Quebec--(Newsfile Corp. - April 12, 2023) - Congruence Therapeutics, a biotechnology company working at the interface of computational and experimental drug discovery to design novel small molecules for diseases of protein misfolding, will be participating in the 2023 Bloom Burton & Co. Healthcare Investor Conference, which will take place on April 25 and 26 at the Metro Toronto Convention Centre. Dates:Tuesday April 25, 2023
2023-04-12 8:00 AM EDT
Bloom Burton & Co. Announces the 2023 Bloom Burton Award
Toronto, Ontario--(Newsfile Corp. - January 25, 2023) - Bloom Burton & Co. ("Bloom Burton") is excited to announce the launch of the 2023 Bloom Burton Award. In addition, Bloom Burton is also announcing that this year's Bloom Burton Award Gala will be held at the Four Seasons Hotel Toronto on Thursday, September 28, 2023. Bestowed annually, the Bloom Burton Award honours an individual scientist, inventor, executive, entrepreneur, industry leader, or policy maker who made the greatest...
2023-01-25 7:30 AM EST
Bloom Burton & Co. Inc. Announces Holdings in NeuPath Health Inc.
Toronto, Ontario--(Newsfile Corp. - November 25, 2022) - Bloom Burton & Co. Inc. announces that 1,000 compensation options (Options) of NeuPath Health Inc. expired unexercised on December 3, 2021, and combined with prior treasury issuances of common shares (Shares) of NeuPath Health, and the expiry of 66,250 Share purchase warrants (Warrants) resulted in a decrease of beneficial holdings to below 10% of the outstanding Shares. Prior to the expiry of the Options, Bloom Burton, beneficially...
2022-11-25 5:30 PM EST
Pieter Cullis Receives the 2022 Bloom Burton Award
Toronto, Ontario--(Newsfile Corp. - September 30, 2022) - Bloom Burton & Co. ("Bloom Burton") is pleased to announce Pieter Cullis, Co-Founder of Acuitas Therapeutics, as the recipient of the 2022 Bloom Burton Award. Pieter Cullis led the development of lipid nanoparticle (LNP) delivery systems for molecular therapeutics at Acuitas Therapeutics. The result of a lifetime of dedicated research driven by scientific curiosity, LNP delivery systems are a critical technology that help to...
2022-09-30 7:27 AM EDT
Three Finalists Announced for the 2022 Bloom Burton Award
Toronto, Ontario--(Newsfile Corp. - May 10, 2022) - Bloom Burton & Co. is pleased to announce the finalists for the 2022 Bloom Burton Award. Bestowed annually and nominated by the public at large, the Bloom Burton Award honours an individual who made the greatest contribution to Canada's innovative healthcare industry in the previous year. The finalists for 2022, in alphabetical order, are: Frank Baylis, Executive Chairman, and Kris Shah, President, Baylis Medical Technologies Pieter Cullis,...
2022-05-10 7:07 AM EDT
Bloom Burton & Co. Announces the 2022 Bloom Burton Award
Toronto, Ontario--(Newsfile Corp. - January 25, 2022) - Bloom Burton & Co. ("Bloom Burton") is excited to announce the launch of the 2022 Bloom Burton Award and the Bloom Burton Award Gala event to be held at the Four Seasons Hotel in Toronto, Ontario, Canada on Thursday, September 29, 2022. Bestowed annually, the Bloom Burton Award honours an individual scientist, inventor, executive, entrepreneur, industry leader, investor or policy maker who made the greatest contribution to Canada's...
2022-01-25 7:00 AM EST
The Bloom Burton Healthcare Lending Trust Named Winner in 2021 Canadian Hedge Fund Awards
Toronto, Ontario--(Newsfile Corp. - October 20, 2021) - The Bloom Burton Healthcare Lending Trust (the "Fund") was recognized for the best 5-year track record in the private debt category at the 2021 Canadian Hedge Fund Awards (CHFA). Bloom Burton Investment Group Inc. is the manager of the Fund as well as the Bloom Burton Canadian Healthcare Fund LP and the Bloom Burton Canadian Healthcare (RSP) Fund, alternative investment funds that focus on investments in the healthcare sector.
2021-10-20 7:00 AM EDT
Carl Hansen Receives the 2021 Bloom Burton Award
Toronto, Ontario--(Newsfile Corp. - October 1, 2021) - Bloom Burton & Co. ("Bloom Burton") is pleased to announce Dr. Carl Hansen of AbCellera Biologics ("AbCellera") as the recipient of the 2021 Bloom Burton Award. From the outset of the COVID-19 pandemic, AbCellera moved from initial screening of blood samples to human clinical trials of its antibody treatment for COVID-19 in 90 days - a process that normally takes years. In the same year, AbCellera's COVID-19 drug, bamlanivimab, was...
2021-10-01 9:48 AM EDT
Three Finalists Announced for the 2021 Bloom Burton Award
Toronto, Ontario--(Newsfile Corp. - April 27, 2021) - Bloom Burton & Co. is pleased to announce the three finalists for the 2021 Bloom Burton Award. Bestowed annually and nominated by the public at large, the Bloom Burton Award honours an individual who made the greatest contribution to Canada's innovative healthcare industry in the previous year. The three finalists are, in alphabetical order: Daniel Durocher, PhD: Scientific Co-founder, Repare Therapeutics; Carl Hansen, PhD: Founder and...
2021-04-27 9:00 AM EDT
Richardson Wealth and Bloom Burton & Co. Announce Strategic Alliance to Expand Wealth Solutions in Healthcare Sector
Toronto, Ontario--(Newsfile Corp. - February 9, 2021) - RF Capital Group Inc. (TSX: RCG) ("RF Capital") today announced that its wholly owned subsidiary Richardson Wealth Limited ("Richardson Wealth") and Bloom Burton & Co. Inc. ("Bloom Burton"), two of Canada's premier independent financial services firms, have entered into a strategic alliance dedicated exclusively on the healthcare sector. This strategic alliance helps unlock growth potential for both firms. Richardson Wealth expands an...
2021-02-09 4:20 PM EST
Bloom Burton & Co. Announces the 2021 Bloom Burton Award
Toronto, Ontario--(Newsfile Corp. - January 25, 2021) - Bloom Burton & Co. ("Bloom Burton") is excited to announce the launch of the 2021 Bloom Burton Award and the Bloom Burton Award Gala event to be held at the Four Seasons Hotel in Toronto, Ontario, Canada on Thursday, September 30, 2021. Bestowed annually, the Bloom Burton Award honours an individual scientist, inventor, executive, entrepreneur, industry leader, investor or policy maker who made the greatest contribution to Canada's...
2021-01-25 9:30 AM EST
Gordon Keller Receives the 2020 Bloom Burton Award
Toronto, Ontario--(Newsfile Corp. - November 26, 2020) - Bloom Burton & Co. is pleased to announce Dr. Gordon Keller as the recipient of the 2020 Bloom Burton Award. Dr. Keller's pioneering academic work in the stem cell therapy field led to the founding of BlueRock Therapeutics in 2016, which was ultimately acquired by Bayer for $1 billion in 2019. BlueRock Therapeutics built out a major laboratory in Toronto, where more than 170 world-class scientists have been recruited to bring new...
2020-11-26 7:15 AM EST
The Bloom Burton Healthcare Lending Trust Named Winner in 2020 Canadian Hedge Fund Awards
Toronto, Ontario--(Newsfile Corp. - October 22, 2020) - The Bloom Burton Healthcare Lending Trust (the "Fund") was named a winner in multiple categories of the 2020 Canadian Hedge Fund Awards (CHFA). Bloom Burton Investment Group Inc. is the manager of the Fund and the Bloom Burton Canadian Healthcare Fund, alternative investment funds that focus on investments in the healthcare sector. The Fund, a private debt fund, won two awards in the private debt category: Best 3-Year Return Best 5-Year...
2020-10-22 7:00 AM EDT